Mutations in MECP2 exon 1 in classical rett patients disrupt MECP2_e1 transcription, but not transcription of MECP2_e2

Peter J. Gianakopoulos, Yuzhi Zhang, Nela Pencea, Marija Orlic-Milacic, Kirti Mittal, Christian Windpassinger, Sara Jane White, Peter M. Kroisel, Eva W C Chow, Carol J. Saunders, Berge A. Minassian, John B. Vincent

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The overwhelming majority of Rett syndrome cases are caused by mutations in the gene MECP2. MECP2 has two isoforms, termed MECP2-e1 and MECP2-e2, which differ in their N-terminal amino acid sequences. A growing body of evidence has indicated that MECP2-e1 may be the etiologically relevant isoform in Rett Syndrome based on its expression profile in the brain and because, strikingly, no mutations have been discovered that affect MECP2-e2 exclusively. In this study we sought to characterize four classical Rett patients with mutations that putatively affect only the MECP2-e1 isoform. Our hypothesis was that the classical Rett phenotype seen here is the result of disrupted MECP2-e1 expression, but with MECP2-e2 expression unaltered. We used quantitative reverse transcriptase PCR to assay mRNA expression for each isoform independently, and used cytospinning methods to assay total MECP2 in peripheral blood lymphocytes (PBL). In the two Rett patients with identical 11bp deletions within the coding portion of exon 1, MECP2-e2 levels were unaffected, whilst a significant reduction of MECP2-e1 levels was detected. In two Rett patients harboring mutations in the exon 1 start codon, MECP2-e1 and MECP2-e2 mRNA amounts were unaffected. In summary, we have shown that patients with exon 1 mutations transcribe normal levels of MECP2-e2 mRNA, and most PBL are positive for MeCP2 protein, despite them theoretically being unable to produce the MECP2-e1 isoform, and yet still exhibit the classical RTT phenotype. Altogether, our work further supports our hypothesis that MECP2-e1 is the predominant isoform involved in the neuropathology of Rett syndrome.

Original languageEnglish (US)
Pages (from-to)210-216
Number of pages7
JournalAmerican Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Volume159 B
Issue number2
DOIs
StatePublished - Mar 1 2012

Fingerprint

Exons
Protein Isoforms
Rett Syndrome
Mutation
Messenger RNA
Methyl-CpG-Binding Protein 2
Lymphocytes
Phenotype
Initiator Codon
Reverse Transcriptase Polymerase Chain Reaction
Amino Acid Sequence
Brain
Genes

Keywords

  • Exon 1
  • Isoforms
  • MECP2
  • Rett syndrome
  • Translation

ASJC Scopus subject areas

  • Genetics(clinical)
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Mutations in MECP2 exon 1 in classical rett patients disrupt MECP2_e1 transcription, but not transcription of MECP2_e2. / Gianakopoulos, Peter J.; Zhang, Yuzhi; Pencea, Nela; Orlic-Milacic, Marija; Mittal, Kirti; Windpassinger, Christian; White, Sara Jane; Kroisel, Peter M.; Chow, Eva W C; Saunders, Carol J.; Minassian, Berge A.; Vincent, John B.

In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 159 B, No. 2, 01.03.2012, p. 210-216.

Research output: Contribution to journalArticle

Gianakopoulos, PJ, Zhang, Y, Pencea, N, Orlic-Milacic, M, Mittal, K, Windpassinger, C, White, SJ, Kroisel, PM, Chow, EWC, Saunders, CJ, Minassian, BA & Vincent, JB 2012, 'Mutations in MECP2 exon 1 in classical rett patients disrupt MECP2_e1 transcription, but not transcription of MECP2_e2', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 159 B, no. 2, pp. 210-216. https://doi.org/10.1002/ajmg.b.32015
Gianakopoulos, Peter J. ; Zhang, Yuzhi ; Pencea, Nela ; Orlic-Milacic, Marija ; Mittal, Kirti ; Windpassinger, Christian ; White, Sara Jane ; Kroisel, Peter M. ; Chow, Eva W C ; Saunders, Carol J. ; Minassian, Berge A. ; Vincent, John B. / Mutations in MECP2 exon 1 in classical rett patients disrupt MECP2_e1 transcription, but not transcription of MECP2_e2. In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 2012 ; Vol. 159 B, No. 2. pp. 210-216.
@article{98e7dba2512a40ef834a7b329b45e587,
title = "Mutations in MECP2 exon 1 in classical rett patients disrupt MECP2_e1 transcription, but not transcription of MECP2_e2",
abstract = "The overwhelming majority of Rett syndrome cases are caused by mutations in the gene MECP2. MECP2 has two isoforms, termed MECP2-e1 and MECP2-e2, which differ in their N-terminal amino acid sequences. A growing body of evidence has indicated that MECP2-e1 may be the etiologically relevant isoform in Rett Syndrome based on its expression profile in the brain and because, strikingly, no mutations have been discovered that affect MECP2-e2 exclusively. In this study we sought to characterize four classical Rett patients with mutations that putatively affect only the MECP2-e1 isoform. Our hypothesis was that the classical Rett phenotype seen here is the result of disrupted MECP2-e1 expression, but with MECP2-e2 expression unaltered. We used quantitative reverse transcriptase PCR to assay mRNA expression for each isoform independently, and used cytospinning methods to assay total MECP2 in peripheral blood lymphocytes (PBL). In the two Rett patients with identical 11bp deletions within the coding portion of exon 1, MECP2-e2 levels were unaffected, whilst a significant reduction of MECP2-e1 levels was detected. In two Rett patients harboring mutations in the exon 1 start codon, MECP2-e1 and MECP2-e2 mRNA amounts were unaffected. In summary, we have shown that patients with exon 1 mutations transcribe normal levels of MECP2-e2 mRNA, and most PBL are positive for MeCP2 protein, despite them theoretically being unable to produce the MECP2-e1 isoform, and yet still exhibit the classical RTT phenotype. Altogether, our work further supports our hypothesis that MECP2-e1 is the predominant isoform involved in the neuropathology of Rett syndrome.",
keywords = "Exon 1, Isoforms, MECP2, Rett syndrome, Translation",
author = "Gianakopoulos, {Peter J.} and Yuzhi Zhang and Nela Pencea and Marija Orlic-Milacic and Kirti Mittal and Christian Windpassinger and White, {Sara Jane} and Kroisel, {Peter M.} and Chow, {Eva W C} and Saunders, {Carol J.} and Minassian, {Berge A.} and Vincent, {John B.}",
year = "2012",
month = "3",
day = "1",
doi = "10.1002/ajmg.b.32015",
language = "English (US)",
volume = "159 B",
pages = "210--216",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Mutations in MECP2 exon 1 in classical rett patients disrupt MECP2_e1 transcription, but not transcription of MECP2_e2

AU - Gianakopoulos, Peter J.

AU - Zhang, Yuzhi

AU - Pencea, Nela

AU - Orlic-Milacic, Marija

AU - Mittal, Kirti

AU - Windpassinger, Christian

AU - White, Sara Jane

AU - Kroisel, Peter M.

AU - Chow, Eva W C

AU - Saunders, Carol J.

AU - Minassian, Berge A.

AU - Vincent, John B.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - The overwhelming majority of Rett syndrome cases are caused by mutations in the gene MECP2. MECP2 has two isoforms, termed MECP2-e1 and MECP2-e2, which differ in their N-terminal amino acid sequences. A growing body of evidence has indicated that MECP2-e1 may be the etiologically relevant isoform in Rett Syndrome based on its expression profile in the brain and because, strikingly, no mutations have been discovered that affect MECP2-e2 exclusively. In this study we sought to characterize four classical Rett patients with mutations that putatively affect only the MECP2-e1 isoform. Our hypothesis was that the classical Rett phenotype seen here is the result of disrupted MECP2-e1 expression, but with MECP2-e2 expression unaltered. We used quantitative reverse transcriptase PCR to assay mRNA expression for each isoform independently, and used cytospinning methods to assay total MECP2 in peripheral blood lymphocytes (PBL). In the two Rett patients with identical 11bp deletions within the coding portion of exon 1, MECP2-e2 levels were unaffected, whilst a significant reduction of MECP2-e1 levels was detected. In two Rett patients harboring mutations in the exon 1 start codon, MECP2-e1 and MECP2-e2 mRNA amounts were unaffected. In summary, we have shown that patients with exon 1 mutations transcribe normal levels of MECP2-e2 mRNA, and most PBL are positive for MeCP2 protein, despite them theoretically being unable to produce the MECP2-e1 isoform, and yet still exhibit the classical RTT phenotype. Altogether, our work further supports our hypothesis that MECP2-e1 is the predominant isoform involved in the neuropathology of Rett syndrome.

AB - The overwhelming majority of Rett syndrome cases are caused by mutations in the gene MECP2. MECP2 has two isoforms, termed MECP2-e1 and MECP2-e2, which differ in their N-terminal amino acid sequences. A growing body of evidence has indicated that MECP2-e1 may be the etiologically relevant isoform in Rett Syndrome based on its expression profile in the brain and because, strikingly, no mutations have been discovered that affect MECP2-e2 exclusively. In this study we sought to characterize four classical Rett patients with mutations that putatively affect only the MECP2-e1 isoform. Our hypothesis was that the classical Rett phenotype seen here is the result of disrupted MECP2-e1 expression, but with MECP2-e2 expression unaltered. We used quantitative reverse transcriptase PCR to assay mRNA expression for each isoform independently, and used cytospinning methods to assay total MECP2 in peripheral blood lymphocytes (PBL). In the two Rett patients with identical 11bp deletions within the coding portion of exon 1, MECP2-e2 levels were unaffected, whilst a significant reduction of MECP2-e1 levels was detected. In two Rett patients harboring mutations in the exon 1 start codon, MECP2-e1 and MECP2-e2 mRNA amounts were unaffected. In summary, we have shown that patients with exon 1 mutations transcribe normal levels of MECP2-e2 mRNA, and most PBL are positive for MeCP2 protein, despite them theoretically being unable to produce the MECP2-e1 isoform, and yet still exhibit the classical RTT phenotype. Altogether, our work further supports our hypothesis that MECP2-e1 is the predominant isoform involved in the neuropathology of Rett syndrome.

KW - Exon 1

KW - Isoforms

KW - MECP2

KW - Rett syndrome

KW - Translation

UR - http://www.scopus.com/inward/record.url?scp=84862960890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862960890&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.32015

DO - 10.1002/ajmg.b.32015

M3 - Article

VL - 159 B

SP - 210

EP - 216

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 2

ER -